The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $42.80

Today's change+0.12 +0.28%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $42.80

Today's change+0.12 +0.28%
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.

Neogen Corp up (U.S.)$0.12

Neogen Corp closed up Wednesday by (U.S.)$0.12 or 0.28% to (U.S.)$42.80. Over the last five days, shares have lost 7.24% and are down 13.69% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $42.70
  • Previous close(U.S.) $42.68
  • High(U.S.) $43.12
  • Low(U.S.) $42.27
  • Bid / Ask(U.S.) $39.80 / (U.S.) $48.00
  • YTD % change-13.69%
  • Volume142,478
  • Average volume (10-day)155,348
  • Average volume (1-month)140,474
  • Average volume (3-month)163,844
  • 52-week range(U.S.) $35.50 to (U.S.) $51.98
  • Beta1.15
  • Trailing P/E50.44×
  • P/E 1 year forward48.26×
  • Forward PEG3.16×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.85
Updated May 6 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.67%

Based on its net profit margin of 11.67%, Neogen Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.99%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Nov 30, 201411/30/2014Aug 31, 201408/31/2014May 31, 201405/31/2014
Revenue68686867
Total other revenue--------
Total revenue68686867
Gross profit34343432
Total cost of revenue35343435
Total operating expense56565456
Selling / general / administrative19191819
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income12131311
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12121411
Income after tax7898
Income tax, total4554
Net income7898
Total adjustments to net income--------
Net income before extra. items7898
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items7898
Inc. avail. to common incl. extra. items7898
Diluted net income8898
Dilution adjustment00----
Diluted weighted average shares38373738
Diluted EPS excluding extraordinary itemsvalue per share0.200.210.240.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.200.210.240.20